Abstract:Metastatic Prostate Cancer (mPCa) is associated with a poor patient prognosis. mPCa spreads throughout the body, often to bones, with spatial and temporal variations that make the clinical management of the disease difficult. The evolution of the disease leads to spatial heterogeneity that is extremely difficult to characterise with solid biopsies. Imaging provides the opportunity to quantify disease spread. Advanced image analytics methods, including radiomics, offer the opportunity to characterise heterogeneity beyond what can be achieved with simple assessment. Radiomics analysis has the potential to yield useful quantitative imaging biomarkers that can improve the early detection of mPCa, predict disease progression, assess response, and potentially inform the choice of treatment procedures. Traditional radiomics analysis involves modelling with hand-crafted features designed using significant domain knowledge. On the other hand, artificial intelligence techniques such as deep learning can facilitate end-to-end automated feature extraction and model generation with minimal human intervention. Radiomics models have the potential to become vital pieces in the oncology workflow, however, the current limitations of the field, such as limited reproducibility, are impeding their translation into clinical practice. This review provides an overview of the radiomics methodology, detailing critical aspects affecting the reproducibility of features, and providing examples of how artificial intelligence techniques can be incorporated into the workflow. The current landscape of publications utilising radiomics methods in the assessment and treatment of mPCa are surveyed and reviewed. Associated studies have incorporated information from multiple imaging modalities, including bone scintigraphy, CT, PET with varying tracers, multiparametric MRI together with clinical covariates, spanning the prediction of progression through to overall survival in varying cohorts. The methodological quality of each study is quantified using the radiomics quality score. Multiple deficits were identified, with the lack of prospective design and external validation highlighted as major impediments to clinical translation. These results inform some recommendations for future directions of the field.

Establishment and validation of novel predictive models to predict bone metastasis in newly diagnosed prostate adenocarcinoma based on single-photon emission computed tomography radiomics

A machine learning radiomics model based on bpMRI to predict bone metastasis in newly diagnosed prostate cancer patients.

Biomarkers for Prostate Cancer Bone Metastasis Detection and Prediction

Bone metastasis prediction in non-small-cell lung cancer: primary CT-based radiomics signature and clinical feature

Preoperative prediction of pelvic lymph nodes metastasis in prostate cancer using an ADC-based radiomics model: comparison with clinical nomograms and PI-RADS assessment

Prediction of clinically significant prostate cancer using radiomics models in real-world clinical practice: a retrospective multicenter study

[The Building and Validation of a Model to Predict the Bone Metastases of Patients with Newly Diagnosed Prostate Cancer].

Development and validation of a radiopathomics model for predicting liver metastases of colorectal cancer

Development and validation of a clinical-radiomics model for prediction of prostate cancer: a multicenter study

A semi-automatic deep learning model based on biparametric MRI scanning strategy to predict bone metastases in newly diagnosed prostate cancer patients

Development and validation of a predictive model based on clinical and MpMRI findings to reduce additional systematic prostate biopsy

A new nomogram for the prediction of bone metastasis in patients with prostate cancer

Development and Validation of 68Ga-Psma-11 PET/CT-based Radiomics Model to Detect Primary Prostate Cancer

Prediction of Prognosis and Response to Androgen Deprivation Therapy in Intermediate to High-Risk Prostate Cancer Using 18 F-FDG PET/CT Radiomics

Radiomics for Identification and Prediction in Metastatic Prostate Cancer: A Review of Studies

MRI-derived radiomics models for diagnosis, aggressiveness, and prognosis evaluation in prostate cancer

Prediction of prostate cancer aggressiveness using magnetic resonance imaging radiomics: a dual-center study

Development of a nomogram predicting metastatic disease and the assessment of NCCN, AUA and EAU guideline recommendations for bone imaging in prostate cancer patients

Magnetic resonance imaging radiomics-based prediction of clinically significant prostate cancer in equivocal PI-RADS 3 lesions in the transitional zone

A PET/CT radiomics model for predicting distant metastasis in early-stage non–small cell lung cancer patients treated with stereotactic body radiotherapy: a multicentric study

Machine Learning and Radiomics of Bone Scintigraphy: Their Role in Predicting Recurrence of Localized or Locally Advanced Prostate Cancer